Stay updated on Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2 (replacing v3.0.1), signaling a version upgrade. A 'Back to Top' link was removed as a minor UI change.
    Difference
    0.3%
    Check dated 2025-09-12T17:18:13.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-05T13:54:49.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as the introduction of new drug names such as itacitinib and INCB039110. However, several important topics related to lung cancer and previous drug information have been removed.
    Difference
    4%
    Check dated 2025-08-29T08:32:09.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-14T23:47:34.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-07T21:58:45.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-07-31T19:32:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Itacitinib for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Itacitinib for NSCLC Clinical Trial page.